Demant A/S

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DK0060738599
DKK
216.40
4.6 (2.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

206.18 k

Shareholding (Dec 2023)

FII

0.00%

Held by 1 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

DKK 46,351 Million ()

stock-summary
P/E

19.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.38

stock-summary
Return on Equity

28.77%

stock-summary
Price to Book

4.93

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.83%
0%
-9.83%
6 Months
-15.07%
0%
-15.07%
1 Year
-20.91%
0%
-20.91%
2 Years
-23.32%
0%
-23.32%
3 Years
4.84%
0%
4.84%
4 Years
-28.63%
0%
-28.63%
5 Years
-0.05%
0%
-0.05%

Demant A/S for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
10.54%
EBIT Growth (5y)
29.16%
EBIT to Interest (avg)
8.07
Debt to EBITDA (avg)
2.24
Net Debt to Equity (avg)
1.30
Sales to Capital Employed (avg)
0.96
Tax Ratio
22.78%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.04%
ROCE (avg)
18.14%
ROE (avg)
28.37%
Valuation key factors
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
5.51
EV to EBIT
15.51
EV to EBITDA
11.47
EV to Capital Employed
2.89
EV to Sales
2.86
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
18.63%
ROE (Latest)
28.77%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Demant A/S"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 15.62% vs 9.14% in Dec 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 12.26% vs -16.05% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "22,549.00",
          "val2": "19,503.00",
          "chgp": "15.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5,560.00",
          "val2": "4,163.00",
          "chgp": "33.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "559.00",
          "val2": "195.00",
          "chgp": "186.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-218.00",
          "val2": "-182.00",
          "chgp": "-19.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,555.00",
          "val2": "2,276.00",
          "chgp": "12.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "187.40%",
          "val2": "153.20%",
          "chgp": "3.42%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
22,549.00
19,503.00
15.62%
Operating Profit (PBDIT) excl Other Income
5,560.00
4,163.00
33.56%
Interest
559.00
195.00
186.67%
Exceptional Items
-218.00
-182.00
-19.78%
Consolidate Net Profit
2,555.00
2,276.00
12.26%
Operating Profit Margin (Excl OI)
187.40%
153.20%
3.42%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is 15.62% vs 9.14% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 12.26% vs -16.05% in Dec 2022

stock-summaryCompany CV
About Demant A/S stock-summary
stock-summary
Demant A/S
Pharmaceuticals & Biotechnology
Demant A/S, formerly William Demant Holding A/S, is a Denmark-based company engaged in the healthcare industry. It develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments, comprising operations of such audiometer companies as Interacoustics, Grason-Stadler, Amplivox, Maico and MedRx, and Personal Communication, which includes the business of Sennheiser Communications, a headset producer. The Company operates globally, through more than 90 subsidiaries and associates worldwide.
Company Coordinates stock-summary
Company Details
Kongebakken 9 , SMOERUM None : 2765
stock-summary
Tel: 45 39 17730045 3913 8967
stock-summary
Registrar Details